Loading…

Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation

Recently, hemoglobin A1c (HgbA1c), microalbumin (MA), C-reactive protein (CRP) and rheumatoid factor (RF) have been introduced on high throughput general chemistry system. We evaluated analytical performance of these assays on an integrated clinical chemistry and immunoassay analyzer and studied the...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta 2006-04, Vol.366 (1), p.204-208
Main Authors: Elefano, Elizabeth C., Jabeen, Rukhsana, Onifade, Kehinde, Okorodudu, A.O., Petersen, J.R., Mohammad, Amin A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3
cites cdi_FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3
container_end_page 208
container_issue 1
container_start_page 204
container_title Clinica chimica acta
container_volume 366
creator Elefano, Elizabeth C.
Jabeen, Rukhsana
Onifade, Kehinde
Okorodudu, A.O.
Petersen, J.R.
Mohammad, Amin A.
description Recently, hemoglobin A1c (HgbA1c), microalbumin (MA), C-reactive protein (CRP) and rheumatoid factor (RF) have been introduced on high throughput general chemistry system. We evaluated analytical performance of these assays on an integrated clinical chemistry and immunoassay analyzer and studied the impact of testing these assays on these systems on the overall efficiency of the analyzer, via computer simulation. The analytical performance was measured by determining precision, linearity and correlation of patient sample results with in-house testing methodology. MedModel simulation software is used to develop simulation model and process efficiency is determined by measuring turnaround times and resource utilization. Between-days CVs ranged from 8.59% for MA to 3.22% for HgbA1c level 1 controls. Less than 2% carryover for all 4 methods was observed on the integrated analyzer. For HgbA1c on HPLC analyzer, the minimum and maximum TAT for a batch of 50 samples was 3.78 and 160 min, respectively, while for the integrated system it was 28.2 and 35.1 min, respectively. Labor utilization for the 2 processes ranged from 3.21% to 3.75%. Chemistry module on an integrated system can be used to determine the HgbA1c and other serum proteins.
doi_str_mv 10.1016/j.cca.2005.10.005
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67714432</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0009898105006005</els_id><sourcerecordid>67714432</sourcerecordid><originalsourceid>FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3</originalsourceid><addsrcrecordid>eNp9kc2OFCEUhYnROD2jD-DGsHLV1QJVUEVcdTrzYzKJZnRPgLrV0lJFC9RM-mV8VunpTnTl6uTCd--FcxB6R8mKEio-7lbW6hUjhJd6VeQFWtCurau6kewlWhBCZNXJjl6gy5R2pWyIoK_RBRWskw0TC_R7PWl_yM5qj-FR-1lnFyYcBny3NWtql3h0NgbtzTy6aYk3D1-XWE89frjBhVtH-8NlsBlb15WHYDdl2EadocfpkDKMz_BTiD8HH57wHuIQ4qgnC_-um5ObttiGcT9niDi5cfbPN2_Qq0H7BG_PeoW-3Vx_39xV919uP2_W95VlQuRKSmr7HgZNhaGGGMupbDQbZA2dZlIwTnvKiewGyxshGtOC5ZZrY3jLTX2FPpym7mP4NUPKanTJgvd6gjAnJdqWNk3NCkhPYLEkpQiD2kc36nhQlKhjJGqnSiTqGMnxqEjpeX8ePpsR-r8d5wwK8OkEQPngo4OoknVQHOpdLM6qPrj_jP8D2jOefA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67714432</pqid></control><display><type>article</type><title>Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Elefano, Elizabeth C. ; Jabeen, Rukhsana ; Onifade, Kehinde ; Okorodudu, A.O. ; Petersen, J.R. ; Mohammad, Amin A.</creator><creatorcontrib>Elefano, Elizabeth C. ; Jabeen, Rukhsana ; Onifade, Kehinde ; Okorodudu, A.O. ; Petersen, J.R. ; Mohammad, Amin A.</creatorcontrib><description>Recently, hemoglobin A1c (HgbA1c), microalbumin (MA), C-reactive protein (CRP) and rheumatoid factor (RF) have been introduced on high throughput general chemistry system. We evaluated analytical performance of these assays on an integrated clinical chemistry and immunoassay analyzer and studied the impact of testing these assays on these systems on the overall efficiency of the analyzer, via computer simulation. The analytical performance was measured by determining precision, linearity and correlation of patient sample results with in-house testing methodology. MedModel simulation software is used to develop simulation model and process efficiency is determined by measuring turnaround times and resource utilization. Between-days CVs ranged from 8.59% for MA to 3.22% for HgbA1c level 1 controls. Less than 2% carryover for all 4 methods was observed on the integrated analyzer. For HgbA1c on HPLC analyzer, the minimum and maximum TAT for a batch of 50 samples was 3.78 and 160 min, respectively, while for the integrated system it was 28.2 and 35.1 min, respectively. Labor utilization for the 2 processes ranged from 3.21% to 3.75%. Chemistry module on an integrated system can be used to determine the HgbA1c and other serum proteins.</description><identifier>ISSN: 0009-8981</identifier><identifier>EISSN: 1873-3492</identifier><identifier>DOI: 10.1016/j.cca.2005.10.005</identifier><identifier>PMID: 16289426</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Albuminuria - urine ; Biomarkers - blood ; Biomarkers - urine ; C-reactive protein ; C-Reactive Protein - analysis ; Clinical Chemistry Tests - instrumentation ; Clinical Chemistry Tests - methods ; Computer Simulation ; Glycated Hemoglobin A - analysis ; Hemoglobin A1c ; Humans ; Integrated chemistry and immunoassay analyzers ; Microalbumin ; Reproducibility of Results ; Rheumatoid factor ; Rheumatoid Factor - blood ; Time Factors ; Workflow</subject><ispartof>Clinica chimica acta, 2006-04, Vol.366 (1), p.204-208</ispartof><rights>2005 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3</citedby><cites>FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16289426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Elefano, Elizabeth C.</creatorcontrib><creatorcontrib>Jabeen, Rukhsana</creatorcontrib><creatorcontrib>Onifade, Kehinde</creatorcontrib><creatorcontrib>Okorodudu, A.O.</creatorcontrib><creatorcontrib>Petersen, J.R.</creatorcontrib><creatorcontrib>Mohammad, Amin A.</creatorcontrib><title>Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation</title><title>Clinica chimica acta</title><addtitle>Clin Chim Acta</addtitle><description>Recently, hemoglobin A1c (HgbA1c), microalbumin (MA), C-reactive protein (CRP) and rheumatoid factor (RF) have been introduced on high throughput general chemistry system. We evaluated analytical performance of these assays on an integrated clinical chemistry and immunoassay analyzer and studied the impact of testing these assays on these systems on the overall efficiency of the analyzer, via computer simulation. The analytical performance was measured by determining precision, linearity and correlation of patient sample results with in-house testing methodology. MedModel simulation software is used to develop simulation model and process efficiency is determined by measuring turnaround times and resource utilization. Between-days CVs ranged from 8.59% for MA to 3.22% for HgbA1c level 1 controls. Less than 2% carryover for all 4 methods was observed on the integrated analyzer. For HgbA1c on HPLC analyzer, the minimum and maximum TAT for a batch of 50 samples was 3.78 and 160 min, respectively, while for the integrated system it was 28.2 and 35.1 min, respectively. Labor utilization for the 2 processes ranged from 3.21% to 3.75%. Chemistry module on an integrated system can be used to determine the HgbA1c and other serum proteins.</description><subject>Albuminuria - urine</subject><subject>Biomarkers - blood</subject><subject>Biomarkers - urine</subject><subject>C-reactive protein</subject><subject>C-Reactive Protein - analysis</subject><subject>Clinical Chemistry Tests - instrumentation</subject><subject>Clinical Chemistry Tests - methods</subject><subject>Computer Simulation</subject><subject>Glycated Hemoglobin A - analysis</subject><subject>Hemoglobin A1c</subject><subject>Humans</subject><subject>Integrated chemistry and immunoassay analyzers</subject><subject>Microalbumin</subject><subject>Reproducibility of Results</subject><subject>Rheumatoid factor</subject><subject>Rheumatoid Factor - blood</subject><subject>Time Factors</subject><subject>Workflow</subject><issn>0009-8981</issn><issn>1873-3492</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNp9kc2OFCEUhYnROD2jD-DGsHLV1QJVUEVcdTrzYzKJZnRPgLrV0lJFC9RM-mV8VunpTnTl6uTCd--FcxB6R8mKEio-7lbW6hUjhJd6VeQFWtCurau6kewlWhBCZNXJjl6gy5R2pWyIoK_RBRWskw0TC_R7PWl_yM5qj-FR-1lnFyYcBny3NWtql3h0NgbtzTy6aYk3D1-XWE89frjBhVtH-8NlsBlb15WHYDdl2EadocfpkDKMz_BTiD8HH57wHuIQ4qgnC_-um5ObttiGcT9niDi5cfbPN2_Qq0H7BG_PeoW-3Vx_39xV919uP2_W95VlQuRKSmr7HgZNhaGGGMupbDQbZA2dZlIwTnvKiewGyxshGtOC5ZZrY3jLTX2FPpym7mP4NUPKanTJgvd6gjAnJdqWNk3NCkhPYLEkpQiD2kc36nhQlKhjJGqnSiTqGMnxqEjpeX8ePpsR-r8d5wwK8OkEQPngo4OoknVQHOpdLM6qPrj_jP8D2jOefA</recordid><startdate>200604</startdate><enddate>200604</enddate><creator>Elefano, Elizabeth C.</creator><creator>Jabeen, Rukhsana</creator><creator>Onifade, Kehinde</creator><creator>Okorodudu, A.O.</creator><creator>Petersen, J.R.</creator><creator>Mohammad, Amin A.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200604</creationdate><title>Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation</title><author>Elefano, Elizabeth C. ; Jabeen, Rukhsana ; Onifade, Kehinde ; Okorodudu, A.O. ; Petersen, J.R. ; Mohammad, Amin A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Albuminuria - urine</topic><topic>Biomarkers - blood</topic><topic>Biomarkers - urine</topic><topic>C-reactive protein</topic><topic>C-Reactive Protein - analysis</topic><topic>Clinical Chemistry Tests - instrumentation</topic><topic>Clinical Chemistry Tests - methods</topic><topic>Computer Simulation</topic><topic>Glycated Hemoglobin A - analysis</topic><topic>Hemoglobin A1c</topic><topic>Humans</topic><topic>Integrated chemistry and immunoassay analyzers</topic><topic>Microalbumin</topic><topic>Reproducibility of Results</topic><topic>Rheumatoid factor</topic><topic>Rheumatoid Factor - blood</topic><topic>Time Factors</topic><topic>Workflow</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Elefano, Elizabeth C.</creatorcontrib><creatorcontrib>Jabeen, Rukhsana</creatorcontrib><creatorcontrib>Onifade, Kehinde</creatorcontrib><creatorcontrib>Okorodudu, A.O.</creatorcontrib><creatorcontrib>Petersen, J.R.</creatorcontrib><creatorcontrib>Mohammad, Amin A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinica chimica acta</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Elefano, Elizabeth C.</au><au>Jabeen, Rukhsana</au><au>Onifade, Kehinde</au><au>Okorodudu, A.O.</au><au>Petersen, J.R.</au><au>Mohammad, Amin A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation</atitle><jtitle>Clinica chimica acta</jtitle><addtitle>Clin Chim Acta</addtitle><date>2006-04</date><risdate>2006</risdate><volume>366</volume><issue>1</issue><spage>204</spage><epage>208</epage><pages>204-208</pages><issn>0009-8981</issn><eissn>1873-3492</eissn><abstract>Recently, hemoglobin A1c (HgbA1c), microalbumin (MA), C-reactive protein (CRP) and rheumatoid factor (RF) have been introduced on high throughput general chemistry system. We evaluated analytical performance of these assays on an integrated clinical chemistry and immunoassay analyzer and studied the impact of testing these assays on these systems on the overall efficiency of the analyzer, via computer simulation. The analytical performance was measured by determining precision, linearity and correlation of patient sample results with in-house testing methodology. MedModel simulation software is used to develop simulation model and process efficiency is determined by measuring turnaround times and resource utilization. Between-days CVs ranged from 8.59% for MA to 3.22% for HgbA1c level 1 controls. Less than 2% carryover for all 4 methods was observed on the integrated analyzer. For HgbA1c on HPLC analyzer, the minimum and maximum TAT for a batch of 50 samples was 3.78 and 160 min, respectively, while for the integrated system it was 28.2 and 35.1 min, respectively. Labor utilization for the 2 processes ranged from 3.21% to 3.75%. Chemistry module on an integrated system can be used to determine the HgbA1c and other serum proteins.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>16289426</pmid><doi>10.1016/j.cca.2005.10.005</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-8981
ispartof Clinica chimica acta, 2006-04, Vol.366 (1), p.204-208
issn 0009-8981
1873-3492
language eng
recordid cdi_proquest_miscellaneous_67714432
source ScienceDirect Freedom Collection 2022-2024
subjects Albuminuria - urine
Biomarkers - blood
Biomarkers - urine
C-reactive protein
C-Reactive Protein - analysis
Clinical Chemistry Tests - instrumentation
Clinical Chemistry Tests - methods
Computer Simulation
Glycated Hemoglobin A - analysis
Hemoglobin A1c
Humans
Integrated chemistry and immunoassay analyzers
Microalbumin
Reproducibility of Results
Rheumatoid factor
Rheumatoid Factor - blood
Time Factors
Workflow
title Analytical evaluation of HgbA1c, microalbumin, CRP, and RF on Architect ci8200 integrated system and workflow performance evaluation using computer simulation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T19%3A52%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analytical%20evaluation%20of%20HgbA1c,%20microalbumin,%20CRP,%20and%20RF%20on%20Architect%20ci8200%20integrated%20system%20and%20workflow%20performance%20evaluation%20using%20computer%20simulation&rft.jtitle=Clinica%20chimica%20acta&rft.au=Elefano,%20Elizabeth%20C.&rft.date=2006-04&rft.volume=366&rft.issue=1&rft.spage=204&rft.epage=208&rft.pages=204-208&rft.issn=0009-8981&rft.eissn=1873-3492&rft_id=info:doi/10.1016/j.cca.2005.10.005&rft_dat=%3Cproquest_cross%3E67714432%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c266t-991cddefa16b1b0bc5194a2f93e8a296251d15098fc54664b7ec5c5abb575b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67714432&rft_id=info:pmid/16289426&rfr_iscdi=true